Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Xerostomia And The Geriatric Patient

J. Ship, S. Pillemer, B. Baum
Published 2002 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Saliva is essential for the preservation of oral‐pharyngeal health, and disorders of salivary physiology are associated with numerous oral and pharyngeal problems, particularly in older people. Although salivary function is remarkably intact in healthy aging, medical problems, medications, and head and neck radiotherapy can cause salivary dysfunction and complaints of xerostomia among older people. Sjögren's syndrome, an autoimmune exocrinopathy, is the most common medical disease associated with salivary dysfunction. Medications with anticholinergic side effects will impair salivary output, and head and neck radiotherapy for cancer will cause permanent destruction of salivary glands. Treatments for salivary problems are based upon establishing a diagnosis, protecting oral and pharyngeal health, stimulating remaining glands, and replacing lost salivary fluids.
This paper references
10.14219/JADA.ARCHIVE.1985.0384
Xerostomia: evaluation of a symptom with increasing significance.
P. Fox (1985)
10.1097/00002281-199709000-00004
Pathogenesis and treatment of Sjögren's syndrome.
R. Fox (1997)
10.1007/S12016-007-8042-1
Sjögren’s Syndrome or Autoimmune Epithelitis?
H. Moutsopoulos (1994)
Cevimeline (Evoxac) for dry mouth.
(2000)
Prevalence of primary Sjögren's syndrome in China.
N. Zhang (1995)
Sjogren's syndrome: A community-based study of prevalence and impact-comment on the article by
M Tomsic (1999)
10.1016/S1368-8375(00)00063-4
Preserved salivary output and xerostomia-related quality of life in head and neck cancer patients receiving parotid-sparing radiotherapy.
B. Henson (2001)
10.1016/0360-3016(94)00361-N
Oral pilocarpine for radiation-induced xerostomia: integrated efficacy and safety results from two prospective randomized clinical trials.
J. Rieke (1995)
10.3322/canjclin.50.1.7
Cancer statistics, 2000
R. Greenlee (2000)
Unique radiosensitivity of serous cells in rhesus monkey submandibular glands.
L. C. Stephens (1986)
10.1016/S0266-4356(97)90683-5
The establishment of a xerostomia clinic: a prospective study.
E. Field (1997)
10.1016/S0360-3016(01)01512-7
Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer.
A. Eisbruch (2001)
10.1177/00220345940730010701
Effects of the β-adrenoceptor Antagonists Atenolol and Propranolol on Human Parotid and Submandibular-Sublingual Salivary Secretion
T. Nederf ors (1994)
10.1002/ART.1780370615
Association of patterns of labial salivary gland inflammation with keratoconjunctivitis sicca. Analysis of 618 patients with suspected Sjögren's syndrome.
T. Daniels (1994)
10.1002/1097-0142(19910315)67:6<1539::AID-CNCR2820670613>3.0.CO;2-Q
Radiation apoptosis of serous acinar cells of salivary and lacrimal glands
L. C. Stephens (1991)
Prednisone and piroxicam for treatment of primary Sjögren's syndrome.
P. Fox (1993)
10.1016/0030-4220(58)90045-8
Secretory sialography in diseases of the major salivary glands.
P. Rubin (1957)
10.1007/s004240050276
Polarized distribution of key membrane transport proteins in the rat submandibular gland
Xinjun He (1996)
10.1111/J.1754-4505.1992.TB00436.X
The role of salivary function on oropharyngeal colonization.
G. Gibson (1992)
10.3322/canjclin.39.6.399
Cancer statistics
N. Dubrawsky (1989)
10.1177/096120339600500108
Treatment of primary Sjögren's syndrome with hydroxychloroquine: a retrospective, open-label study.
R. Fox (1996)
10.1016/S0360-3016(99)00550-7
Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer.
L. Dawson (2000)
10.1177/00220345000790090301
Low Unstimulated Salivary Flow and Subjective Oral Dryness: Association with Medication, Anxiety, Depression, and Stress
M. Bergdahl (2000)
10.1177/096120339600500108
Respiratory function in systemic lupus erythematosus: relation with activity and severity
G. Rolla (1996)
Time-dose-volume relations in radiation therapy
JT Parsons (1994)
Zur Kenntnis der Keratoconjunktivitis Sicca (Keratitis Filiformis bei Hypofunktion der Tränedrusen)
H. Sjögren (1933)
10.1177/00220345840630100101
Basic Biological Sciences Unstimulated and Stimulated Parotid Salivary Flow Rate in Individuals of Different Ages
M. Heft (1984)
10.1016/0030-4220(88)90268-X
Xerostomia. Part I: Relationship to other oral symptoms and salivary gland hypofunction.
L. Sreebny (1988)
10.1002/ART.1780330307
Dissociation of immune responses to the SS-A (Ro) 52-kd and 60-kd polypeptides in systemic lupus erythematosus and Sjögren's syndrome.
E. Ben‐Chetrit (1990)
10.1159/000061125
Receptors in Salivary Glands
B. J. Baum (1999)
Normal salivary gland function: How much saliva is enough
JA Ship (1991)
Viruses in the etiopathogenesis of Sjögren's syndrome.
P. Venables (1997)
10.1111/J.1600-0528.1993.TB01105.X
Mouth dryness as reported by older Floridians.
G. H. Gilbert (1993)
10.1177/00220345000790080601
Association of Salivary Flow Rates with Maximal Bite Force
C. Yeh (2000)
10.1177/00220345940730010301
Prevalence of Subjective Feelings of Dry Mouth in the Elderly
T. Närhi (1994)
10.1111/j.1749-6632.1993.tb18339.x
Mechanisms of Fluid Secretion by Salivary Glands
R. J. Turner (1993)
Circadian rhythms in the flow rate and composition of unstimu542 SHIP ET AL. MARCH 2002–VOL. 50, NO. 3 JAGS lated and stimulated human submandibular saliva
C. Dawes (1975)
10.1016/0360-3016(81)90140-1
Some factors influencing salivary function when treating with radiotherapy.
J. Mira (1981)
Secretion by the major salivary glands
DI Cook (1994)
Adverse effects associated with selective serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis.
E. Trindade (1998)
10.1111/J.1754-4505.1999.TB01363.X
The occurrence of xerostomia and salivary gland hypofunction in a population-based sample of older South Australians.
W. Thomson (1999)
10.1177/10454411000110010301
Regulation of calcium in salivary gland secretion.
I. Ambudkar (2000)
10.14219/JADA.ARCHIVE.1989.0211
The role of saliva in maintaining oral homeostasis.
I. Mandel (1989)
Costs of illness and the burden of disease.
A. Maetzel (1997)
10.1016/S1079-2104(97)90341-3
Salivary flow and composition in elderly patients referred to an acute care geriatric ward.
H. Pajukoski (1997)
10.1111/J.1600-0528.1993.TB00744.X
Subjective reports of oral dryness in an older adult population.
D. Locker (1993)
Management of dry mouth.
P. Fox (1997)
10.1177/10454411950060040501
Does variability in salivary protein concentrations influence oral microbial ecology and oral health?
J. Rudney (1995)
Conformal and intensity modulated irradiation of head and neck cancer: the potential for improved target irradiation, salivary gland function, and quality of life.
A. Eisbruch (1999)
10.1111/J.1741-2358.1995.TB00133.X
Salivary gland hypofunction in elderly patients attending a xerostomia clinic.
L. Longman (1995)
10.1111/J.1365-2842.1984.TB00565.X
Salivary flow, saliva, pH and buffering capacity in 70-year-old men and women. Correlation to dental health, dryness in the mouth, disease and drug treatment.
T. Osterberg (1984)
10.4065/76.6.593
Incidence of physician-diagnosed primary Sjögren syndrome in residents of Olmsted County, Minnesota.
S. Pillemer (2001)
10.1093/RHEUMATOLOGY/27.2.123
Prevalence of primary Sjögren's syndrome in an elderly population.
A. Drosos (1988)
10.1016/S0360-3016(96)00264-7
Parotid gland sparing in patients undergoing bilateral head and neck irradiation: techniques and early results.
A. Eisbruch (1996)
10.1097/00005792-196505000-00001
SJÖGREN'S SYNDROME: A Clinical, Pathological, and Serological Study of Sixty-two Cases
K. Bloch (1965)
10.1016/S0360-3016(98)00082-0
Comprehensive irradiation of head and neck cancer using conformal multisegmental fields: assessment of target coverage and noninvolved tissue sparing.
A. Eisbruch (1998)
10.1111/j.1749-6632.1993.tb18338.x
Principles of Saliva Secretion
B. Baum (1993)
10.1136/ard.52.5.360
Hydroxychloroquine treatment for primary Sjögren's syndrome: a two year double blind crossover trial.
A. Kruize (1993)
Sjogren’s syndrome: A community-based study of prevalence and impact—comment on the article by Thomas et al. Rheumatology (Oxford) 1999;38:685–686
M Tomsic (1999)
10.1089/10763270050044380
The growth and morphological behavior of salivary epithelial cells on matrix protein-coated biodegradable substrata.
D. Aframian (2000)
Evaluation of stimulated parotid saliva flow rate in different age groups.
B. Baum (1981)
Oral complications of cancer therapies. Management of salivary dysfunction.
D. Greenspan (1990)
10.1097/00002281-199809000-00009
Evolving concepts of diagnosis, pathogenesis, and therapy of Sjögren's syndrome.
R. Fox (1998)
10.1111/J.1600-0714.1994.TB00060.X
Stimulated parotid salivary flow rates in normotensive, hypertensive, and hydrochlorothiazide-medicated.
C. Streckfus (1994)
10.1093/GERONA/52A.5.M310
The relationship between dehydration and parotid salivary gland function in young and older healthy adults.
J. Ship (1997)
10.1254/JJP.82.281
Prospects for gene-based immunopharmacology in salivary glands.
S. Yamano (2000)
Chemoprotective and radioprotective effects of amifostine: an update of clinical trials.
R. Capizzi (2000)
10.3109/10408368009108733
Sialochemistry in diseases and clinical situations affecting salivary glands.
I. Mandel (1980)
Sex hormones and Sjögren's syndrome.
D. Sullivan (1997)
10.1111/J.1600-0528.1997.TB00928.X
Prevalence of perceived symptoms of dry mouth in an adult Swedish population--relation to age, sex and pharmacotherapy.
T. Nederfors (1997)
10.1016/0003-9969(95)00079-5
The effects of antidepressant drugs on salivary flow and content of sodium and potassium ions in human parotid saliva.
K. D. Hunter (1995)
10.1074/jbc.273.24.14659
The Aquaporins, Blueprints for Cellular Plumbing Systems*
P. Agre (1998)
10.1016/S0360-3016(96)00557-3
Concomitant pilocarpine during head and neck irradiation is associated with decreased posttreatment xerostomia.
R. P. Zimmerman (1997)
A multicenter maintenance study of oral pilocarpine tablets for radiation-induced xerostomia.
C. Jacobs (1996)
10.1097/00002281-200009000-00007
Update in Sjögren syndrome.
R. Fox (2000)
10.1152/AJPLEGACY.1954.178.1.155
Excretion of sodium, potassium, chloride and carbon dioxide in human parotid saliva.
J. H. Thaysen (1954)
10.1001/ARCHINTE.159.12.1359
Dry eye and dry mouth in the elderly: a population-based assessment.
O. Schein (1999)
Xerostomia: prevalence and pharmacotherapy. With special reference to beta-adrenoceptor antagonists.
T. Nederfors (1996)
10.1093/GERONA/50A.5.M285
Longitudinal analysis of parotid and submandibular salivary flow rates in healthy, different-aged adults.
J. Ship (1995)
10.1177/00220345000790100601
Immunoquantification of Human Salivary Mucins MG1 and MG2 in Stimulated whole Saliva: Factors Influencing Mucin levels
S.A. Payment (2000)
10.1113/jphysiol.1975.sp010811
Circadian rhythms in the flow rate and composition of unstimulated and stimulated human submandibular saliva.
C. Dawes (1975)
10.1177/00220345810600070101
Clinical Science
B. Baum (1981)
10.1177/00220345000790111001
Determination of Variation of Stimulated Salivary Flow Rates
E. Ghezzi (2000)
10.1016/0360-3016(93)90143-J
Major salivary gland function in patients with radiation-induced xerostomia: flow rates and sialochemistry.
I. H. Valdez (1993)
10.1034/J.1600-0528.2000.280108.X
Salivary flow and oral complaints in adult dental patients.
M. Bergdahl (2000)
Sialadenitis following I-131 therapy for thyroid carcinoma: concise communication.
P. Allweiss (1984)
10.1200/JCO.1993.11.6.1124
A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients.
F. G. Leveque (1993)
10.1097/00005537-199608000-00011
Determination of the Efficacy of Topical Oral Pilocarpine for Postirradiation Xerostomia in Patients With Head and Neck Carcinoma
D. Hamlar (1996)
10.1093/AGEING/1.4.197
Sjögren's syndrome and autoimmunity in a geriatric population.
K. Whaley (1972)
10.1016/S0360-3016(99)00247-3
Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer.
A. Eisbruch (1999)
10.1093/CLINIDS/16.SUPPLEMENT_4.S314
Bacterial colonization of saliva and plaque in the elderly.
M. Terpenning (1993)
10.1111/j.1749-6632.1999.tb08512.x
Re‐engineering the Functions of a Terminally Differentiated Epithelial Cell in Vivo
B. Baum (1999)
10.14219/JADA.ARCHIVE.1991.0098
How Much Saliva is Enough
J. Ship (1991)
10.1016/S1079-2104(97)90143-8
Five-year follow-up of saliva in patients treated for lymphomas.
J. Meurman (1997)
10.14219/JADA.ARCHIVE.1994.0059
Salivary gland dysfunction: causes, symptoms, treatment.
J. Atkinson (1994)
Oral pilocarpine for radiationinduced xerostomia: Integrated efficacy and safety results from two prospective randomized clinical trials
JW Rieke (1995)
Stimulated parotid gland salivary flow rates in normotensive, hypertensive, and hydrochlorothiazide-medicated African Americans
CF Streckfus (1994)
10.1007/s005200050150
Radiochemotherapy with amifostine cytoprotection for head and neck cancer
J. Buentzel (1998)
10.1016/0896-8411(89)90185-6
Dry eyes or mouth--an epidemiological study in Swedish adults, with special reference to primary Sjögren's syndrome.
L. Jacobsson (1989)
10.1093/GERONJ/47.5.M137
Use of medications by persons 65 and over: data from the established populations for epidemiologic studies of the elderly.
E. Chrischilles (1992)
10.1097/00055735-199808000-00009
Advances in the diagnosis and management of keratoconjunctivitis sicca.
S. Pflugfelder (1998)
10.4088/JCP.V60N1009
Donepezil for psychotropic-induced memory loss.
F. M. Jacobsen (1999)
10.1111/j.1532-5415.1997.tb01517.x
Oropharyngeal Candidosis in the Older Patient
K. Shay (1997)
Hypofunction of the stress axis in Sjögren's syndrome.
E. Johnson (1998)
10.1023/A:1008282412670
Selective cytoprotection with amifostine in concurrent radiochemotherapy for head and neck cancer.
J. Buentzel (1998)
10.1093/GERONJ/48.5.M219
Cross-sectional and longitudinal analyses of stimulated parotid salivary constituents in healthy, different-aged subjects.
A. J. Wu (1993)
10.1001/ARCHINTE.159.2.174
Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjögren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 Study Group.
F. Vivino (1999)
10.1111/J.1754-4505.1994.TB01112.X
Oral side-effects of the most frequently prescribed drugs.
R. G. Smith (1994)
10.1111/J.1834-7819.1985.TB04132.X
The effects of fractionated megavoltage X-irradiation on rat submandibular gland: an assessment by electron microscopy.
N. Savage (1985)
10.1001/JAMA.1971.03180390021005
Xerostomia in Sjögren's syndrome. Evaluation by sequential salivary scintigraphy.
G. Schall (1971)
10.1016/0964-1955(96)00037-1
Oral health care for the cancer patient.
C. Scully (1996)
10.1002/1529-0131(199908)42:8<1765::AID-ANR28>3.0.CO;2-V
Malignant lymphoma in primary Sjögren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjögren's Syndrome.
M. Voulgarelis (1999)
10.1111/J.1754-4505.1998.TB00914.X
Salivary sIgA concentrations and stimulated whole saliva flow rates among women undergoing chemotherapy for breast cancer: an exploratory study.
T. Harrison (1998)
10.1016/0140-6736(90)93212-8
Is reduced salivary flow normal in old people?
J. Ship (1990)
Viruses in the etiopathogenesis of Sjögren's syndrome.
Venables Pj (1997)
10.1111/J.1600-0722.1989.TB00926.X
Effects of the thiazide diuretic bendroflumethiazide on salivary flow rate and composition.
T. Nederfors (1989)
Sjögren's syndrome: a critical review of clinical management.
M. Bell (1999)
10.1016/S0749-0690(18)30460-9
Salivary gland dysfunction.
J. Atkinson (1992)
10.1017/S0022215100127768
A comparison of artificial saliva and pilocarpine in radiation-induced xerostomia.
A. N. Davies (1994)
10.1093/RHEUMATOLOGY/38.7.685
Sjögren's syndrome: a community-based study of prevalence and impact--comment on the article by Thomas et al.
M. Tomšič (1999)
10.1016/S1368-8375(98)00104-3
Two-year longitudinal study of parotid salivary flow rates in head and neck cancer patients receiving unilateral neck parotid-sparing radiotherapy treatment.
B. Henson (1999)
10.1016/S1079-2104(05)80276-8
A longitudinal follow-up of salivary secretion in bone marrow transplant patients.
G. Chaushu (1995)
10.1517/13543784.9.9.2007
Sjögren’s syndrome: current therapies remain inadequate for a common disease
R. Fox (2000)
10.1016/0030-4220(93)90258-6
A characterization of major salivary gland flow rates in the presence of medications and systemic diseases.
A. J. Wu (1993)
A double blind placebo controlled trial of azathioprine in the treatment of primary Sjögren's syndrome.
E. J. Price (1998)
10.1002/1529-0131(200007)43:7<1647::AID-ANR31>3.0.CO;2-P
Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndrome.
S. Waterman (2000)
10.1097/00005792-199211000-00005
Sjögren's syndrome. A clinical, pathological, and serological study of sixty-two cases. 1965.
K. J. Bloch (1992)
The effect of radiation on normal tissues of the head and neck
JT Parsons (1994)
10.1177/00220345870660S207
Physiological Factors Affecting Salivary Flow Rate, Oral Sugar Clearance, and the Sensation of Dry Mouth in Man
C. Dawes (1987)
10.1111/J.1600-0722.1995.TB01856.X
Effects of the antihypertensive drug captopril on human salivary secretion rate and composition.
T. Nederfors (1995)
10.1111/j.1532-5415.1995.tb05815.x
Xerostomia, Xerogenic Medications and Food Avoidances in Selected Geriatric Groups
W. Loesche (1995)
10.1111/J.1399-302X.1995.TB00143.X
Age-related changes in immunoglobulin isotypes in whole and parotid saliva and serum in healthy individuals.
S. Challacombe (1995)
10.1093/RHEUMATOLOGY/37.10.1069
Sjögren's syndrome: a community-based study of prevalence and impact.
E. Thomas (1998)
Five-year follow-up of saliva in patients treated for lymphomas. Oral Surg Oral Med Oral Path Oral Radiol
J H Meurman (1997)
10.1177/10454411990100030701
Oral colonization by Candida albicans.
R. Cannon (1999)
10.1176/AJP.155.7.914
Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia.
R. Conley (1998)
10.1177/00220345970760031401
Parotid Sparing Study in Head and Neck Cancer Patients Receiving Bilateral Radiation Therapy: One-year Results
J. Ship (1997)
The frequency of sicca syndrome in an elderly female population.
R. Strickland (1987)
10.1016/S0149-2918(98)80033-7
Oropharyngeal candidiasis: a review of its clinical spectrum and current therapies.
J. Epstein (1998)
10.1016/S0901-5027(00)80086-7
Salivary glands as a model for craniofacial applications of gene transfer.
B. Baum (2000)
10.1111/j.1600-0447.1997.tb09953.x
Long‐term efficacy and safety of milnacipran compared to clomipramine in patients with major depression
E. Leinonen (1997)
10.1111/J.1741-2358.1997.00033.X
A reference guide to drugs and dry mouth--2nd edition.
L. Sreebny (1997)
Methotrexate in primary Sjögren's syndrome.
F. Skopouli (1996)
10.1016/S0049-0172(99)80001-8
Sjögren's syndrome comes of age.
J. Anaya (1999)
10.1136/ard.55.2.116
Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome.
C. Vitali (1996)
A longitudinal follow-up of salivary secretion in bone marrow transplant patients. Oral Surg Oral Med Oral Path Oral Radiol Endo
G Chaushu (1995)
10.1016/S0964-1955(97)00037-7
Five-year follow-up study of saliva, mutans streptococci, lactobacilli and yeast counts in lymphoma patients.
J. Meurman (1997)
10.1056/NEJM199308053290603
Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer.
J. Johnson (1993)
10.1182/blood.v90.2.766.766_766_775
Lymphomas in patients with Sjogren's syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses.
B. Royer (1997)
10.7326/0003-4819-89-6-888
Increased risk of lymphoma in sicca syndrome.
S. Kassan (1978)



This paper is referenced by
EPIDERMAL GROWTH FACTOR PROMOTES THE PROLIFERATION AND DIFFERENTIATION OF PROGENITOR CELLS DURING WOUND HEALING OF RAT SUBMANDIBULAR GLANDS
F. Kobayashi (2016)
10.1111/ger.12415
Factors associated with hyposalivation and xerostomia in older persons in South Brazil.
R. Rech (2019)
10.1016/J.ARCHORALBIO.2004.10.015
Influence of the time of measurement of unstimulated human whole saliva on the diagnosis of hyposalivation.
H. Flink (2005)
Where Dysphagia Begins: Polypharmacy and Xerostomia.
Stephen Marcott (2020)
La malattia reumatica nel paziente anziano Rheumatic disease in the elderly
Nicola Bizzaro (2011)
ssessment of Age-Related orphological and Functional Changes of elected Structures of the Head and Neck by omputed Tomography , Magnetic Resonance maging , and Positron Emission Tomography
nton Mahne (2007)
10.1007/s00455-017-9867-2
Relationship Between Frequency of Spontaneous Swallowing and Salivary Substance P Level in Patients with Acute Stroke
M. Niimi (2017)
10.2334/josnusd.17-0150
Expression of aquaporin 3 and 5 as a potential marker for distinguishing dry mouth from Sjögren's syndrome.
T. Ichiyama (2018)
10.1111/ger.12441
Basic survey for the prevention of intraoral residual medication in older adults: A pilot study.
Yoko Hasegawa (2019)
10.1111/ger.12081
Developing pathways for oral care in elders: evidence-based interventions for dental caries prevention in dentate elders.
E. Ghezzi (2014)
10.1111/adj.12283
Oral medicine and the ageing population.
T. Yap (2015)
10.1016/j.dental.2016.08.214
Effect of surface treatments on the mechanical properties and antimicrobial activity of desiccated glass ionomers.
Jennifer Simmons (2016)
10.1016/j.tripleo.2011.01.042
A retrospective, cohort study of the prevalence and risk factors of oral burning in patients with dry mouth.
T. Rouleau (2011)
10.1111/j.1601-0825.2006.01339.x
Restoring the function of salivary glands.
H. Kagami (2008)
10.1016/j.adaj.2017.01.020
Using the Beers criteria to identify potentially inappropriate medication use by older adult dental patients.
Daniel D. Skaar (2017)
10.1111/J.1754-4505.2006.TB01434.X
Exposure to the oral side effects of medication in a community-based sample.
R. Shinkai (2006)
10.1111/j.1741-2358.2009.00293.x
Medication in elderly people: its influence on salivary pattern, signs and symptoms of dry mouth.
S. Leal (2010)
On The Innervation of Salivary Glands and Treatment of Dry Mouth - An Experimental and Clinical Study
N. Khosravani (2009)
Review article Annals and Essences of Dentistry
Smita I. Musani (2010)
10.5368/AEDJ.2010.2.3.137-140.PDF
Xerostomia: Dental Implications And Management
Ram (2010)
An Expert Opinion from the ECG and the EUGMS: European Policy Recommendations on Oral Health in Older Adults
Justyna Hajto-Bryk (2018)
10.17219/acem/104601
Does oral dryness influence quality of life? Current perspectives in elderly dental care.
Katarzyna Skośkiewicz-Malinowska (2019)
10.1023/B:MCBI.0000028748.40917.6f
Effects of diabetes mellitus on salivary secretion and its composition in the human
A. Mata (2004)
10.1111/odi.13152
Improvement of dry mouth following intraductal irrigation of salivary glands.
D. Aframian (2019)
10.1016/J.CADMOS.2012.05.002
Xerostomia: dall’eziologia al trattamento
S. Decani (2012)
10.1385/1-59259-831-5:063
Bidirectional Impact of Oral Health and General Health
A. Kamer (2005)
10.1002/msj.21292
Perioperative dental evaluation.
Jeffrey S Yasny (2012)
10.1111/odi.13195
Sex Differences in the Hypothalamic-Pituitary-Adrenal Axis in Patients with Burning Mouth Syndrome.
Y. Lee (2019)
10.1016/j.tripleo.2009.01.024
Serum and stimulated whole saliva parathyroid hormone in menopausal women with oral dry feeling.
F. Agha-Hosseini (2009)
Xerostomia and its Dental Implications : A Review Contact
Sowmya (2014)
10.1093/mmy/myv103
Reliability of the agar based method to assess the production of degradative enzymes in clinical isolates of Candida albicans.
Paula Tamião Arantes (2016)
10.1007/BF03324623
Age-related changes in unstimulated salivary function and composition and its relations to medications and oral sensorial complaints
R. Nagler (2005)
See more
Semantic Scholar Logo Some data provided by SemanticScholar